Akero Therapeutics, Inc. (AKRO) Revenue History
Annual and quarterly revenue from 2017 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
AKRO Revenue Growth
AKRO Revenue Analysis (2017–2024)
As of May 8, 2026, Akero Therapeutics, Inc. (AKRO) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q3 2025) recorded $0 in revenue.
Looking at the longer-term picture, AKRO's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including MDGL (+256.8% YoY), HALO (+37.6% YoY), and NVCR (+8.5% YoY). Compare AKRO vs MDGL →
AKRO Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| AKROCurrent | $0 | - | - | - | |
 MDGL | $958M | +256.8% | - | -31.3% | |
 HALO | $1.4B | +37.6% | +39.2% | 58.4% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% |
AKRO Historical Revenue Data (2017–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | - | $0 | - | $-285,423,000 | - |
| 2023 | $0 | - | $0 | - | $-172,870,000 | - |
| 2022 | $0 | - | $0 | - | $-115,156,000 | - |
| 2021 | $0 | - | $0 | - | $-100,886,000 | - |
| 2020 | $0 | - | $-213,000 | - | $-80,154,000 | - |
| 2019 | $0 | - | $0 | - | $-45,651,000 | - |
| 2018 | $0 | - | $0 | - | $-13,778,000 | - |
| 2017 | $0 | - | $0 | - | $-4,564,000 | - |
See AKRO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AKRO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare AKRO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonAKRO — Frequently Asked Questions
Quick answers to the most common questions about buying AKRO stock.
Is AKRO's revenue growth accelerating or slowing?
AKRO TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is AKRO's long-term revenue growth rate?
Akero Therapeutics, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is AKRO's revenue distributed by segment?
AKRO reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2017-2024 are available for download. Segment mix reveals concentration and diversification trends.